| |
| |
|
| Insider
Information: |
Karabelas Argeris N |
| Relationship: |
|
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
130,211 |
|
|
Indirect Shares
|
3,405,909 |
|
|
| Direct
Value |
$904,788 |
|
|
|
Indirect Value
|
$48,548,603 |
|
|
| Total
Shares |
3,536,120 |
|
|
| Total
Value |
$49,453,391 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Anadys Pharmaceuticals Inc |
ANDS |
Director |
|
0 |
2004-03-18 |
1,128,770 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
Director |
|
0 |
2010-03-12 |
0 |
Premium* |
|
|
Biodelivery Sciences Internation... |
BDSI |
10% Owner |
2009-06-17 |
0 |
2009-07-16 |
0 |
Premium* |
|
|
Human Genome Sciences Inc |
HGSI |
Director |
2012-07-30 |
0 |
2006-11-10 |
0 |
Premium* |
|
|
Rocket Pharmaceuticals |
RCKT |
Director, 10% Owner |
|
0 |
2015-02-23 |
2,277,139 |
Premium* |
|
|
Bausch Health Companies Inc |
BHC |
Director |
2022-06-24 |
123,715 |
2016-06-17 |
0 |
Premium* |
|
|
Regenxbio Inc. |
RGNX |
|
2023-06-02 |
6,496 |
2022-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RCKT |
Rocket Pharmaceuticals |
Director |
– • • |
2015-02-23 |
4 |
B |
$6.00 |
$3,622,992 |
I/I |
603,832 |
2,277,139 |
2.25 |
- |
|
| RCKT |
Rocket Pharmaceuticals |
Director |
– • • |
2015-02-23 |
4 |
A |
$0.00 |
$0 |
I/I |
1,458,205 |
1,673,307 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-06-17 |
4 |
S |
$6.40 |
$640,180 |
I/I |
(100,000) |
1,295,000 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-06-18 |
4 |
S |
$6.50 |
$412,219 |
I/I |
(63,391) |
1,231,609 |
0 |
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
Director |
– • – |
2004-03-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,128,770 |
|
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-06-19 |
4 |
S |
$6.54 |
$723,515 |
I/I |
(110,614) |
1,120,995 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-06-22 |
4 |
S |
$6.56 |
$76,433 |
I/I |
(11,657) |
1,109,338 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-06-23 |
4 |
S |
$6.30 |
$206,758 |
I/I |
(32,800) |
1,076,538 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-06-24 |
4 |
S |
$6.48 |
$81,423 |
I/I |
(12,559) |
1,063,979 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-06-25 |
4 |
S |
$6.51 |
$253,498 |
I/I |
(38,965) |
1,025,014 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2009-10-13 |
4 |
S |
$12.65 |
$3,004,375 |
I/I |
(237,500) |
762,500 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2009-12-04 |
4 |
S |
$11.70 |
$1,170,000 |
I/I |
(100,000) |
662,500 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2009-12-07 |
4 |
S |
$11.57 |
$1,157,000 |
I/I |
(100,000) |
562,500 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-06-26 |
4 |
S |
$6.85 |
$3,273,181 |
I/I |
(477,509) |
547,505 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2009-12-08 |
4 |
S |
$11.30 |
$298,049 |
I/I |
(26,376) |
536,124 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2009-12-09 |
4 |
S |
$11.57 |
$1,240,304 |
I/I |
(107,200) |
428,924 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-06-29 |
4 |
S |
$6.88 |
$1,484,232 |
I/I |
(215,791) |
331,714 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chairman of the Board |
• • – |
2006-11-17 |
4 |
S |
$14.25 |
$3,847,500 |
I/I |
(270,000) |
313,705 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chairman of the Board |
• • – |
2006-11-20 |
4 |
S |
$15.29 |
$764,500 |
I/I |
(50,000) |
310,495 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-06-30 |
4 |
S |
$6.68 |
$217,918 |
I/I |
(32,640) |
299,074 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2009-12-14 |
4 |
S |
$11.14 |
$1,448,200 |
I/I |
(130,000) |
298,924 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-07-01 |
4 |
S |
$6.76 |
$337,760 |
I/I |
(50,000) |
249,074 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
10% Owner |
– – • |
2009-07-02 |
4 |
S |
$6.45 |
$42,004 |
I/I |
(6,511) |
242,563 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Chairman of the Board |
• • – |
2006-04-18 |
4 |
A |
$0.00 |
$0 |
I/I |
3,612,665 |
232,000 |
|
- |
|
| RCKT |
Rocket Pharmaceuticals |
Director |
– • • |
2015-02-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
215,102 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
